Actively Recruiting
Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma
Led by West China Hospital · Updated on 2025-04-30
50
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In recent years, researchers have conducted extensive studies on adjuvant therapy following surgical resection of liver cancer, exploring its potential benefits and seeking effective treatment strategies. Given the rarity and high aggressiveness of primary hepatic sarcomatoid carcinoma, there is a lack of reliable clinical evidence on whether postoperative adjuvant therapy can benefit patients, resulting in the absence of established standard guidelines. Therefore, we conducted a single-center retrospective study to assess the potential benefits of postoperative adjuvant therapy for patients of primary hepatic sarcomatoid carcinoma.
CONDITIONS
Official Title
Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who underwent liver resection
- Patients diagnosed with primary hepatic sarcomatoid carcinoma confirmed by postoperative pathology and immunohistochemistry
You will not qualify if you...
- Patients who received other anti-tumor treatments before surgery such as radiofrequency ablation, transarterial chemoembolization, radiation therapy, or systemic therapy
- Patients diagnosed with other specific types of sarcomas
- Patients with other concurrent malignancies during the course of PHSC
- Patients who were lost to follow-up or lacked essential clinical data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
West China Hospital
Chengdu, Sichuan, China, 610041
Actively Recruiting
Research Team
J
Jiwei Huang Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here